Mosaic ImmunoEngineering, Inc.
CPMV
$0.75
$0.42127.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -1.42% | -12.60% | -37.83% | -21.09% | -40.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.40% | -22.53% | -45.72% | -34.97% | -45.50% |
| Operating Income | 1.40% | 22.53% | 45.72% | 34.97% | 45.50% |
| Income Before Tax | -12.28% | 11.41% | 42.25% | 37.16% | 49.05% |
| Income Tax Expenses | -100.00% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.52% | 11.41% | 41.44% | 37.16% | 48.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.52% | 11.41% | 41.44% | 37.16% | 48.24% |
| EBIT | 1.40% | 22.53% | 45.72% | 34.97% | 45.50% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -10.90% | 11.24% | 41.38% | 37.09% | 48.28% |
| Normalized Basic EPS | -12.31% | 11.18% | 42.13% | 36.69% | 48.82% |
| EPS Diluted | -19.41% | 11.24% | 41.38% | 37.09% | 41.91% |
| Normalized Diluted EPS | -12.31% | 11.18% | 42.13% | 36.69% | 48.82% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |